Cáncer Renal segunda línea - page 18

McDermott DF, et al. J Clin Oncol 2016; 34 (suppl): Abstract 4307
Survival by subgroups in phase III CheckMate
025 study with Nivolumab
1...,8,9,10,11,12,13,14,15,16,17 19,20,21,22,23,24,25,26,27,28,...35
Powered by FlippingBook